Authors: Miric, G Dallemagne, C Endre, Z Margolin, S Taylor, SM Brown, L

Citation: G. Miric et al., Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats, BR J PHARM, 133(5), 2001, pp. 687-694

Authors: Mesa, RA Tefferi, A Elliott, MA Hoagland, HC Call, TG Schroeder, GS Yoon, SY Li, CY Gray, LA Margolin, S Hook, CC

Citation: Ra. Mesa et al., A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), a novel anti-fibrosing agent, in myelofibrosis with myeloid metaplasia, BR J HAEM, 114(1), 2001, pp. 111-113

Authors: Cain, WC Stuart, RW Lefkowitz, DL Starnes, JD Margolin, S Lefkowitz, SS

Citation: Wc. Cain et al., Inhibition of tumor necrosis factor and subsequent endotoxin shock by pirfenidone, INT J IMMUN, 20(12), 1998, pp. 685-695